John B. Thomas
Corporate Officer/Principal bij NIRI NY Chapter
Profiel
John B.
Thomas is a professional with a background in investor relations and public affairs.
He is currently a member of the NIRI NY Chapter.
Previously, he held positions as Vice President of Investor Relations & Public Affairs at Abbott Laboratories from 1995 to 2013, SVP of Investor Relations & Corporate Communications at Assertio Therapeutics, Inc., and Executive VP of Strategy & Investor Relations at Horizon Therapeutics Plc from 2015 to 2017.
He also served as President of Abbott Fund.
Thomas received his undergraduate degree from the University of Mississippi in 1985 and his MBA from Lake Forest Graduate School of Management in 2001.
Actieve functies van John B. Thomas
| Bedrijven | Functie | Begin |
|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - |
Eerdere bekende functies van John B. Thomas
| Bedrijven | Functie | Einde |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Contact | 01-01-2017 |
| ABBOTT LABORATORIES | Investor Relations Contact | 01-05-2013 |
| Abbott Fund | President | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Contact | - |
| University of Mississippi | Corporate Officer/Principal | - |
Opleiding van John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| Abbott Fund | |
| NIRI NY Chapter |
